Cargando…

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro

Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monome...

Descripción completa

Detalles Bibliográficos
Autores principales: Marotta, Nicholas P., Ara, Jahan, Uemura, Norihito, Lougee, Marshall G., Meymand, Emily S., Zhang, Bin, Petersson, E. James, Trojanowski, John Q., Lee, Virginia M.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611971/
https://www.ncbi.nlm.nih.gov/pubmed/34819159
http://dx.doi.org/10.1186/s40478-021-01288-2
_version_ 1784603395285319680
author Marotta, Nicholas P.
Ara, Jahan
Uemura, Norihito
Lougee, Marshall G.
Meymand, Emily S.
Zhang, Bin
Petersson, E. James
Trojanowski, John Q.
Lee, Virginia M.-Y.
author_facet Marotta, Nicholas P.
Ara, Jahan
Uemura, Norihito
Lougee, Marshall G.
Meymand, Emily S.
Zhang, Bin
Petersson, E. James
Trojanowski, John Q.
Lee, Virginia M.-Y.
author_sort Marotta, Nicholas P.
collection PubMed
description Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monomers into fibrils occurs readily in vitro and pre-formed fibrils (PFFs) generated from recombinant α-Syn monomers are the basis of many models of LB diseases. These α-Syn PFFs recapitulate many pathological phenotypes in both cultured cells and animal models including the formation of α-Syn rich, insoluble aggregates, neuron loss, and motor deficits. However, it is not clear how closely α-Syn PFFs recapitulate the biological behavior of LB aggregates isolated directly from patients. Direct interrogation of the cellular response to LB-derived α-Syn has thus far been limited. Here we demonstrate that α-Syn aggregates derived from LB disease patients induce pathology characterized by a prevalence of large somatic inclusions that is distinct from the primarily neuritic pathology induced by α-Syn PFFs in our cultured neuron model. Moreover, these LB-derived aggregates can be amplified in vitro using recombinant α-Syn to generate aggregates that maintain the unique, somatic pathological phenotype of the original material. Amplified LB aggregates also showed greater uptake in cultured neurons and greater pathological burden and more rapid pathological spread in injected mouse brains, compared to α-Syn PFFs. Our work indicates that LB-derived α-Syn from diseased brains represents a distinct conformation species with unique biological activities that has not been previously observed in fully recombinant α-Syn aggregates and demonstrate a new strategy for improving upon α-Syn PFF models of synucleinopathies using amplified LBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01288-2.
format Online
Article
Text
id pubmed-8611971
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86119712021-11-29 Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro Marotta, Nicholas P. Ara, Jahan Uemura, Norihito Lougee, Marshall G. Meymand, Emily S. Zhang, Bin Petersson, E. James Trojanowski, John Q. Lee, Virginia M.-Y. Acta Neuropathol Commun Research Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monomers into fibrils occurs readily in vitro and pre-formed fibrils (PFFs) generated from recombinant α-Syn monomers are the basis of many models of LB diseases. These α-Syn PFFs recapitulate many pathological phenotypes in both cultured cells and animal models including the formation of α-Syn rich, insoluble aggregates, neuron loss, and motor deficits. However, it is not clear how closely α-Syn PFFs recapitulate the biological behavior of LB aggregates isolated directly from patients. Direct interrogation of the cellular response to LB-derived α-Syn has thus far been limited. Here we demonstrate that α-Syn aggregates derived from LB disease patients induce pathology characterized by a prevalence of large somatic inclusions that is distinct from the primarily neuritic pathology induced by α-Syn PFFs in our cultured neuron model. Moreover, these LB-derived aggregates can be amplified in vitro using recombinant α-Syn to generate aggregates that maintain the unique, somatic pathological phenotype of the original material. Amplified LB aggregates also showed greater uptake in cultured neurons and greater pathological burden and more rapid pathological spread in injected mouse brains, compared to α-Syn PFFs. Our work indicates that LB-derived α-Syn from diseased brains represents a distinct conformation species with unique biological activities that has not been previously observed in fully recombinant α-Syn aggregates and demonstrate a new strategy for improving upon α-Syn PFF models of synucleinopathies using amplified LBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01288-2. BioMed Central 2021-11-24 /pmc/articles/PMC8611971/ /pubmed/34819159 http://dx.doi.org/10.1186/s40478-021-01288-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Marotta, Nicholas P.
Ara, Jahan
Uemura, Norihito
Lougee, Marshall G.
Meymand, Emily S.
Zhang, Bin
Petersson, E. James
Trojanowski, John Q.
Lee, Virginia M.-Y.
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title_full Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title_fullStr Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title_full_unstemmed Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title_short Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
title_sort alpha-synuclein from patient lewy bodies exhibits distinct pathological activity that can be propagated in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611971/
https://www.ncbi.nlm.nih.gov/pubmed/34819159
http://dx.doi.org/10.1186/s40478-021-01288-2
work_keys_str_mv AT marottanicholasp alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT arajahan alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT uemuranorihito alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT lougeemarshallg alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT meymandemilys alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT zhangbin alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT peterssonejames alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT trojanowskijohnq alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro
AT leevirginiamy alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro